Axogen AXGN
NASDAQ AXGN
$37.39 -2.53 (-6.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Axogen (AXGN) Gains from Sales and Divestitures (2018)

Updated

Axogen (AXGN) reported Gains from Sales and Divestitures of -$56,000 for FY2023.

Analysis

Axogen (AXGN) Gains from Sales and Divestitures (2018) Analysis & Trends

Dating back to FY2012, Axogen's Gains from Sales and Divestitures record includes 4 years.

  • The FY2023 figure ranks as the highest annual Gains from Sales and Divestitures since FY2020.
  • According to Business Quant data, Gains from Sales and Divestitures came in at -$3,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Axogen 2.01 Bn 1.72 Bn 50.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 361.00
API Access

Axogen Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=AXGN&period=max&api_key=YOUR_API_KEY